ATE344048T1 - Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe - Google Patents

Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe

Info

Publication number
ATE344048T1
ATE344048T1 AT98938319T AT98938319T ATE344048T1 AT E344048 T1 ATE344048 T1 AT E344048T1 AT 98938319 T AT98938319 T AT 98938319T AT 98938319 T AT98938319 T AT 98938319T AT E344048 T1 ATE344048 T1 AT E344048T1
Authority
AT
Austria
Prior art keywords
supplement
extracts
flavonoid
containing natural
food supplements
Prior art date
Application number
AT98938319T
Other languages
English (en)
Inventor
Lynn Perkes
Original Assignee
Melaleuca Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melaleuca Inc filed Critical Melaleuca Inc
Application granted granted Critical
Publication of ATE344048T1 publication Critical patent/ATE344048T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
AT98938319T 1997-08-06 1998-08-05 Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe ATE344048T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90731797A 1997-08-06 1997-08-06

Publications (1)

Publication Number Publication Date
ATE344048T1 true ATE344048T1 (de) 2006-11-15

Family

ID=25423886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938319T ATE344048T1 (de) 1997-08-06 1998-08-05 Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe

Country Status (10)

Country Link
US (1) US6818233B2 (de)
EP (1) EP1009417B1 (de)
JP (1) JP4047538B2 (de)
CN (2) CN1268891A (de)
AT (1) ATE344048T1 (de)
AU (1) AU731089B2 (de)
CA (1) CA2244512C (de)
DE (1) DE69836335T2 (de)
TW (1) TW542721B (de)
WO (1) WO1999007400A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229651B2 (en) * 1997-08-06 2007-06-12 Melaleuca, Inc. Dietary supplements containing natural ingredients
US20040219682A1 (en) * 1997-09-18 2004-11-04 Ridgway Helen Jane Single-tube method and system for platelet function analysis
US6410337B1 (en) * 1997-09-18 2002-06-25 Helena Laboratories Corporation Method of platlet function analysis using platelet count
US20040219681A1 (en) * 1997-09-18 2004-11-04 Ridgway Helen Jane Two-tube method and system for platelet function analysis using platelet count
GB2361185A (en) 2000-04-10 2001-10-17 Nicholas J Wald Pharmaceutical formulation for the prevention of cardiovascular disease
TWI226221B (en) * 2000-06-14 2005-01-11 Otsuka Pharma Co Ltd Method for producing acidic beverage
WO2002005827A2 (en) * 2000-07-18 2002-01-24 Forum Bioscience Use of natural products in cancer treatment
CN1111068C (zh) * 2000-07-27 2003-06-11 上海北医大生物科技有限公司 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法
US7138262B1 (en) 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
US20020192314A1 (en) * 2001-03-06 2002-12-19 Cho Suk H. Dietary supplement compositions
US20050019742A1 (en) * 2002-10-15 2005-01-27 Jennings Lisa K. Methods for assessment of platelet aggregation
US20040186782A1 (en) * 2003-03-21 2004-09-23 Andrew Schydlowsky Custom food
ES2228284B1 (es) * 2003-03-24 2006-07-16 Agustin Soriano Casani Composiciones que comprenden un extracto de hollejo, semillas y raspas de uva negra.
ITAN20030053A1 (it) * 2003-10-08 2005-04-09 Mauro Angeletti Processo per la produzione di estratto da semi d'uva a basso contenuto di polifenoli monomerici
US20050196389A1 (en) * 2004-03-08 2005-09-08 Nena Dockery Chlorella containing nutritional supplement having improved digestability
BRPI0402260B1 (pt) 2004-06-15 2015-02-18 Botica Com Farmaceutica Ltda Composição para produtos de higiene, cosméticos e perfumes.
WO2005122793A1 (en) * 2004-06-18 2005-12-29 Unilever N.V. Food composition with wine extract and grape juice extract
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
FR2882502B1 (fr) * 2005-02-25 2007-04-20 Claude Bonne Complements alimentaires destines aux patients atteints de psoriasis
CA2620013A1 (en) * 2005-08-23 2007-03-01 Wellgen, Inc. Methods for managing adipocyte fat accumulation
ES2391657T3 (es) 2006-02-07 2012-11-28 Shire Human Genetic Therapies, Inc. Composiciones estabilizadas de proteínas que tienen un resto tiol libre
CA2641950A1 (en) * 2006-02-10 2007-08-23 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
KR100650364B1 (ko) 2006-07-14 2006-11-30 바이오비즈(주) 은행나무 수피로부터 분리한 신규 화합물을 포함하는항혈소판제 조성물
KR100857061B1 (ko) 2007-03-09 2008-09-05 주식회사태준제약 바키늄 미르틸루스 추출물을 함유하는 정제 및 이의 제조방법
US20100247670A1 (en) * 2009-03-26 2010-09-30 Dmitriy Shoutov Red Grape Dry Composition and Health Tea
AU2010281403B2 (en) 2009-07-28 2016-03-10 Takeda Pharmaceutical Company Limited Compositions and methods for treating Gaucher disease
WO2013130963A1 (en) 2012-03-02 2013-09-06 Shire Human Genetic Therapies, Inc. Compositions and methods for treating type iii gaucher disease
US20140314729A1 (en) * 2013-04-12 2014-10-23 Creative Medical Health Inc. Nutraceutical formulation for treatment of elevated cholesterol and cardiovascular disease
TWI788111B (zh) * 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
WO2016109853A2 (en) 2015-01-02 2016-07-07 Melaleuca, Inc. Dietary supplement compositions
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615721A (en) 1967-12-26 1971-10-26 Philip Morris Inc Method for the manufacture of food from plant material
US4393085A (en) 1981-08-13 1983-07-12 General Foods Corporation Enzyme digestion for a dog food of improved palatability
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4737364A (en) 1986-02-06 1988-04-12 Kalogris Theodore P Nutritional dry food concentrate
JPS6379834A (ja) 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
US5484594A (en) 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
US5308627A (en) 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
JP3134233B2 (ja) 1991-07-26 2001-02-13 株式会社林原生物化学研究所 α−グリコシル ケルセチンとその製造方法並びに用途
US5387422A (en) * 1993-03-11 1995-02-07 Triarco Industries, Inc. Proteolytic fungal enzyme food supplement composition
US5589182A (en) 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5567424A (en) * 1994-06-10 1996-10-22 Reliv International, Inc. Fiber, antioxidant, herbal and enzyme supplemented beverage composition for human consumption
US5569458A (en) * 1994-09-14 1996-10-29 Greenberg; Mike Nutritional formula
US5626849A (en) 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6054128A (en) 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
WO1999007400A1 (en) 1999-02-18
CN101849675B (zh) 2013-02-20
JP2001513332A (ja) 2001-09-04
CA2244512A1 (en) 1999-02-06
AU8686898A (en) 1999-03-01
CA2244512C (en) 2009-01-06
JP4047538B2 (ja) 2008-02-13
AU731089B2 (en) 2001-03-22
EP1009417A4 (de) 2002-10-28
US20020048575A1 (en) 2002-04-25
CN101849675A (zh) 2010-10-06
HK1027973A1 (en) 2001-02-02
DE69836335D1 (de) 2006-12-14
DE69836335T2 (de) 2007-05-24
EP1009417A1 (de) 2000-06-21
TW542721B (en) 2003-07-21
EP1009417B1 (de) 2006-11-02
CN1268891A (zh) 2000-10-04
US6818233B2 (en) 2004-11-16

Similar Documents

Publication Publication Date Title
DE69836335D1 (de) Natürliche inhaltsstoffe enthaltende nahrungsergänzungsstoffe
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
ATE264093T1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
EP0374440A3 (de) Hemmer der Lysyl-Oxydase
ATE484595T1 (de) Pflanzen-sterol-acyltransferasen
WO2002091858A8 (en) Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
MX9708202A (es) Extracto flavonoidico de ginkgo biloba que esta libre de terpenos, y/o tiene un alto contenido de heterosidos de flavonoides.
Azzi Antioxidants: Wonder drugs or quackery?
PT1063901E (pt) Alimentos contendo biotina e outras vitaminas b
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
Rautalahti et al. Antioxidants and carcinogenesis
DE60135927D1 (en) Nd
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
Nardini et al. Lipid peroxidation in liver microsomes of rats fed soybean, olive, and coconut oil
DE69630666D1 (de) Wirkstoff für verbesserten fettstoffwechsel
MY120958A (en) Use of a flavonoid extract of ginkgo biloba leaves, and more specifically of a terpene-free extract, in the pharmaceutical and/or cosmetic domain and more particularly in the buccodental domain
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
US20080031861A1 (en) Dietary supplements containing natural ingredients
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
ATE275835T1 (de) Zinc und linolsäure enthaltendes nährungsmittel
Sözmen et al. Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model. Effect of nicardipine
PT1007034E (pt) Combinacoes que contem bergamotina para aumentar a biodisponibilidade oral de agentes farmaceuticos
WO1996036330A3 (en) Compositions containing fatty acids for improving digestion and absorption in the small intestine
Mashino et al. Antioxidant activity and xanthine oxidase inhibition activity of reductic acid: ascorbic acid analogue

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties